Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry

PURPOSE: Advanced chronic kidney disease (CKD), including end-stage renal disease (ESRD) on dialysis, increases thromboembolic risk among patients with atrial fibrillation (AF). This study examined the comparative safety and efficacy of direct-acting oral anticoagulant (DOAC) compared to warfarin or...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hanjin, Yu, Hee Tae, Kim, Tae-Hoon, Park, Junbeom, Park, Jin-Kyu, Kang, Ki-Woon, Shim, Jaemin, Kim, Jin-Bae, Kim, Jun, Choi, Eue-Keun, Park, Hyung Wook, Lee, Young Soo, Joung, Boyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826956/
https://www.ncbi.nlm.nih.gov/pubmed/36579375
http://dx.doi.org/10.3349/ymj.2022.0455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826956/
https://www.ncbi.nlm.nih.gov/pubmed/36579375
http://dx.doi.org/10.3349/ymj.2022.0455

Ejemplares similares